VEGFA and age-related macular degeneration: The VEGF-Trap Eye Investigation of Efficacy and Safety of Wet Age-related Macular Degeneration (VIEW 1) and VIEW 2 demonstrated that 8 weekly administrations of aflibercept (2.0 mg/0.05 mL) following a loading phase with 3 monthly injections, resulted in a similar visual improvement when compared with a 4-weekly administration of ranibizumab (0.5 mg/0.05 mL) [30].